Joost de Bruijn
Fundador en KUROS BIOSCIENCES AG .
Fortuna: 10 M $ al 30/04/2024
Cargos activos de Joost de Bruijn
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
KUROS BIOSCIENCES AG | Director/Miembro de la Junta | 14/06/2018 | - |
Director Técnico/Científico/I+D | 12/10/2023 | - | |
Fundador | - | - | |
Director Ejecutivo | 04/12/2017 | 12/10/2023 | |
University of London | Corporate Officer/Principal | 18/03/2014 | - |
Presidente | - | 18/03/2014 | |
Queen Mary University of London | Corporate Officer/Principal | 01/01/2004 | - |
Historial de carrera de Joost de Bruijn
Antiguos cargos conocidos de Joost de Bruijn.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
University of Twente | Corporate Officer/Principal | 01/01/2011 | 01/01/2019 |
Scinus Cell Expansion BV | Fundador | - | - |
IsoTis SA
IsoTis SA BiotechnologyHealth Technology IsoTis SA develops biomedical products. Its product include proprietary natural and synthetic bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Lausanne, Switzerland. | Director Técnico/Científico/I+D | - | - |
Xpand Biotechnology BV
Xpand Biotechnology BV BiotechnologyHealth Technology Xpand Biotechnology BV develops innovative technologies in the area of cell cultivation and regenerative medicine. Its bioreactor system enables clinical scale cell cultivation in a controlled environment and provides a cost effective alternative to 2 dimensional cell growth in tissue culture flasks or cell stacks. The company was founded by Joost D. de Bruijin and Frank-Jan van der Velden in 2004 and is headquartered in Bilthoven, the Netherlands. | Director Ejecutivo | 01/01/2005 | - |
Fundador | 01/01/2005 | - | |
Presidente | 01/01/2005 | - | |
Progentix Orthobiology BV
Progentix Orthobiology BV Medical SpecialtiesHealth Technology Progentix Orthobiology BV develops CuriOs (TM), a unique suite of osteoconductive material products for clinical application in bone regenerative surgery. The company was founded by Joost Dick de Bruijn and Clemens A. van Blitterswijk in 2007 and is headquartered in Bilthoven, the Netherlands. | Director Ejecutivo | 01/01/2007 | - |
Fundador | 15/04/2010 | - |
Formación de Joost de Bruijn.
University of Leiden | Doctorate Degree |
Estadísticas
Internacional
Países Bajos | 6 |
Suiza | 3 |
Reino Unido | 3 |
Operativa
Founder | 4 |
Chief Executive Officer | 3 |
Corporate Officer/Principal | 3 |
Sectorial
Health Technology | 5 |
Consumer Services | 5 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
KUROS BIOSCIENCES AG | Health Technology |
Empresas privadas | 4 |
---|---|
Progentix Orthobiology BV
Progentix Orthobiology BV Medical SpecialtiesHealth Technology Progentix Orthobiology BV develops CuriOs (TM), a unique suite of osteoconductive material products for clinical application in bone regenerative surgery. The company was founded by Joost Dick de Bruijn and Clemens A. van Blitterswijk in 2007 and is headquartered in Bilthoven, the Netherlands. | Health Technology |
IsoTis SA
IsoTis SA BiotechnologyHealth Technology IsoTis SA develops biomedical products. Its product include proprietary natural and synthetic bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Lausanne, Switzerland. | Health Technology |
Xpand Biotechnology BV
Xpand Biotechnology BV BiotechnologyHealth Technology Xpand Biotechnology BV develops innovative technologies in the area of cell cultivation and regenerative medicine. Its bioreactor system enables clinical scale cell cultivation in a controlled environment and provides a cost effective alternative to 2 dimensional cell growth in tissue culture flasks or cell stacks. The company was founded by Joost D. de Bruijin and Frank-Jan van der Velden in 2004 and is headquartered in Bilthoven, the Netherlands. | Health Technology |
Scinus Cell Expansion BV |
- Bolsa de valores
- Insiders
- Joost de Bruijn
- Experiencia